Randomized Controlled Trial of Lorcaserin for Cannabis Use Disorder
Phase: EARLY_PHASE1
Conditions: Cannabis Use Disorder
Sponsor: New York State Psychiatric Institute

 
 
 
 
 
 
Study: #7662 “A randomized controlled trial of Lorcaserin for Cannabis Use Disorder” 
 
PI: Christina Brezing, MD 
NCT# NCT03637842 
Protocol approved: 9-21-2018